That UTSW/PPHM license was in July 2016, no doubt negotiated earlier. Do we know when Dr. Schroit and team began their work? When did exosome technology become a "hot topic" as a diagnostic?
Just another Carrot by Management. BOD consists of group of individuals known to decrease shareholder value.
CEO is just inexperienced and should have resigned after the P2 debacle. Totally lack of responsibility even if it was out of his control. The responsibility still lies with the top person.
Still waiting for the praises for Management after the next reverse split.